Actively Recruiting

Phase 2
Age: 0 - 60Years
All Genders
NCT05735717

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Led by Masonic Cancer Center, University of Minnesota · Updated on 2026-04-06

70

Participants Needed

1

Research Sites

394 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a phase II, open-label, prospective study of T cell receptor alpha/beta depletion (TCR α/β TCD) peripheral blood stem cell (PBSC) transplantation for children and adults with hematological malignancies. This is a safety/feasibility study of the investigational procedure/product.

CONDITIONS

Official Title

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Who Can Participate

Age: 0 - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Histological confirmation of hematological malignancies
  • Diagnosis of acute leukemias including AML and related precursor neoplasms
  • Favorable risk AML defined by specific criteria
  • Acute lymphoblastic leukemia (ALL) or lymphoma
  • Myelodysplasia (MDS) IPSS INT-2 or High Risk including RAEB, RAEBt, or severe pancytopenia
  • Age 60 years or younger at consent
  • Karnofsky performance status ≥ 70% or Lansky play score ≥ 50% for age ≤16 years
  • Adequate organ function
Not Eligible

You will not qualify if you...

  • Pregnant or breastfeeding
  • Active uncontrolled infection within 1 week before starting preparative therapy
  • Known HIV positive or active Hepatitis B or C with detectable viral load
  • Prior autologous or allogeneic transplant
  • Chronic myelogenous leukemia (CML) blast crisis
  • Active central nervous system malignancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Minnesota Masonic Cancer Center

Minneapolis, Minnesota, United States, 55455

Actively Recruiting

Loading map...

Research Team

M

Margaret MacMillan

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

8

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here